Shan-Yan Gao

Dr. Shan-Yan Gao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
TZTie-Ning Zhang
Tie-Ning Zhang
XHXin-Mei Huang
Xin-Mei Huang
XZXin-Yi Zhao
Xin-Yi Zhao
WWWei Wang
Wei Wang
RWRi Wen
Ri Wen
SGShan-Yan Gao
Shan-Yan Gao
Background: Pre-gestational diabetes mellitus (PGDM) has been known to be a risk factor for congenital heart defects (CHDs) for decades. However, the associations between maternal PGDM and gestational diabetes mellitus (GDM) and the risk of specific types of CHDs and congenital anomalies (CAs) in other systems remain under debate. We aimed to investigate type-specific CAs in offspring of women with diabetes and to examine the extent to which types of maternal diabetes are associated with increased risk of CAs in offspring.Methods and findings: We searched PubMed and Embase from database inception to 15 October 2021 for population-based studies reporting on type-specific CAs in offspring born to women with PGDM (combined type 1 and 2) or GDM, with no limitation on language. Reviewers extracted data for relevant outcomes and performed random effects meta-analyses, subgroup analyses, and multivariable meta-regression. Risk of bias appraisal was performed using the Cochrane Risk of Bias Tool. This study was registered in PROSPERO (CRD42021229217). Primary outcomes were overall CAs and CHDs. Secondary outcomes were type-specific CAs. Overall, 59 population-based studies published from 1990 to 2021 with 80,437,056 participants met the inclusion criteria. Of the participants, 2,407,862 (3.0%) women had PGDM and 2,353,205 (2.9%) women had GDM. The meta-analyses showed increased risks of overall CAs/CHDs in offspring born to women with PGDM (for overall CAs, relative risk [RR] = 1.99, 95% CI 1.82 to 2.17,P< 0.001; for CHDs, RR = 3.46, 95% CI 2.77 to 4.32,P< 0.001) or GDM (for overall CAs, RR = 1.18, 95% CI 1.13 to 1.23,P< 0.001; for CHDs, RR = 1.50, 95% CI 1.38 to 1.64,P< 0.001). The results of the meta-regression analyses showed significant differences in RRs of CAs/CHDs in PGDM versus GDM (allP< 0.001). Of the 23 CA categories, excluding CHD-related categories, in offspring, maternal PGDM was associated with a significantly increased risk of CAs in 21 categories; the corresponding RRs ranged from 1.57 (for hypospadias, 95% CI 1.22 to 2.02) to 18.18 (for holoprosencephaly, 95% CI 4.03 to 82.06). Maternal GDM was associated with a small but significant increase in the risk of CAs in 9 categories; the corresponding RRs ranged from 1.14 (for limb reduction, 95% CI 1.06 to 1.23) to 5.70 (for heterotaxia, 95% CI 1.09 to 29.92). The main limitation of our analysis is that some high significant heterogeneity still persisted in both subgroup and sensitivity analyses.Conclusions: In this study, we observed an increased rate of CAs in offspring of women with diabetes and noted the differences for PGDM versus GDM. The RRs of overall CAs and CHDs in offspring of women with PGDM were higher than those in offspring of women with GDM. Screening for diabetes in pregnant women may enable better glycemic control, and may enable identification of offspring at risk for CAs.

20 May 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
TZTie-Ning Zhang
Tie-Ning Zhang
WWWei Wang
Wei Wang
XHxinmei Huang
xinmei Huang
SGShan-Yan Gao
Shan-Yan Gao
Gestational diabetes mellitus (GDM) is defined as glucose intolerance with onset or first recognition in the second or third trimester of pregnancy. GDM has a considerable impact on health outcomes of the mother and offspring during pregnancy, delivery, and beyond. Although the exact mechanism regarding GDM remains unclear, numerous studies have suggested that non-coding RNAs, including long non-coding (lnc)RNAs, microRNAs, and circular RNAs, were involved in the pathogenesis of GDM in which they played vital regulatory roles. Additionally, several studies have revealed that extracellular vehicles also participated in the pathogenesis of GDM, highlighting their important role in this disease. Considering the lack of effective biomarkers for the early identification of and specific treatment for GDM, non-coding RNAs and extracellular vehicles may be promising biomarkers and even targets for GDM therapies. This review provides an update on our understanding of the role of non-coding RNAs and extracellular vehicles in GDM. As our understanding of the function of lncRNAs and extracellular vehicles improves, the future appears promising for their use as potential biomarkers and treatment targets for GDM in clinical practice.

15 August 2025 in Psychological Medicine
Verified
Journal Article
Open access
DLDong-Run Li
Dong-Run Li
ZLZheng-Xuan Li
Zheng-Xuan Li
MLMing-Hui Li
Ming-Hui Li
BLBang-Quan Liu
Bang-Quan Liu
QFQian Fang
Qian Fang
Qi-Jun WuQi-Jun Wu
Qi-Jun Wu
Background: Depression and anxiety are prevalent mental health disorders. While sleep duration has been extensively studied, sleep regularity may play a critical role. We aimed to examine associations between objectively measured sleep regularity and incident depression and anxiety and to investigate whether meeting recommended sleep duration modifies these associations. Methods: In 79,666 UK Biobank participants without baseline depression or anxiety, wrist accelerometers worn for 7 days yielded a sleep regularity index (SRI) and average sleep duration. SRI was categorized as irregular (≤51), moderately irregular (52–70), or regular (≥71). Sleep duration was classified by age-specific recommendations (7–9 hours for ages 18–64 years; 7–8 hours for over 65 years). Cox regression models assessed associations between sleep parameters and mental health outcomes. Results: During a median follow-up of 7.5 years, 1,646 participants developed depression, and 2,097 developed anxiety. Compared to irregular sleepers, regular sleepers had a 38% lower depression risk (hazard ratio [HR], 0.62; 95% confidence interval [CI], 0.52–0.73) and a 33% lower anxiety risk (HR, 0.67; 95%CI, 0.58–0.77). Participants with both irregular sleep and nonrecommended duration exhibited the highest risks (depression HR, 1.91; 95%CI, 1.55–2.35; anxiety HR, 1.61; 95%CI, 1.35–1.93). Notably, irregular sleepers who met duration guidelines still faced elevated risks (depression HR, 1.48; 95%CI, 1.18–1.86; anxiety HR, 1.35; 95%CI, 1.11–1.64). Conclusions: Greater sleep regularity is independently associated with lower depression and anxiety risk regardless of sleep duration, suggesting that sleep–wake consistency should be considered in mental health promotion strategies alongside traditional sleep duration recommendations.

17 May 2025 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
DLDong-Run Li
Dong-Run Li
BLBang-Quan Liu
Bang-Quan Liu
MLMing-Hui Li
Ming-Hui Li
YQYing Qin
Ying Qin
JLJia-Cheng Liu
Jia-Cheng Liu
Qi-Jun WuQi-Jun Wu
Qi-Jun Wu
Background: The dietary index for gut microbiota (DI-GM) is a newly proposed index that evaluates dietary intake patterns associated with gut microbial health. Limited studies have examined whether DI-GM influences gastrointestinal (GI) cancer risk. We aimed to investigate the association between DI-GM and GI cancer risk and evaluate its combined effect with genetic risk. Methods: We included 178,148 UK Biobank participants who completed at least one 24-hour dietary recall. DI-GM was constructed from 13 dietary components known to influence gut microbial health and was divided into three groups. The GI cancer polygenic risk score was calculated from 205 significant single-nucleotide polymorphisms related to esophageal cancer (EC), gastric cancer (GC), and colorectal cancer (CRC). Cox proportional hazards models with hazard ratios (HRs) and 95% confidence intervals (CIs) were used to estimate the associations between DI-GM, genetic risk, and GI cancer. Results: During a median follow-up of 13.47 years, 2,682 participants developed GI cancer. In fully adjusted models, higher DI-GM was associated with a lower GI cancer risk (HR for GI cancer: 0.83; 95% CI: 0.75–0.92; HR for EC: 0.62, 95% CI: 0.45–0.86; HR for GC: 0.99, 95% CI: 0.71–1.39; HR for CRC: 0.84, 95% CI: 0.75–0.95), compared with participants in the lowest DI-GM category. In joint analysis, individuals with higher DI-GM and lower genetic risk had lower GI cancer risk, with HRs (95% CI) of 0.28 (0.21, 0.36), 0.50 (0.42, 0.58) for low and intermediate genetic risk, respectively, compared with those with low DI-GM and high genetic risk. And a significant interaction between DI-GM and genetic risk was observed. Conclusion: Higher DI-GM was associated with a lower risk of GI cancer including EC and CRC. These findings highlight the importance of considering a gut microbiota-friendly diet and genetic risk in GI cancer prevention.

3 January 2026 in Age and Ageing
Verified
Journal Article
Closed access
HLHao-Yu Liu
Hao-Yu Liu
YLYu-Yang Liu
Yu-Yang Liu
QLQian-Man Li
Qian-Man Li
LLLu Liu
Lu Liu
TWTian-Jiao Wen
Tian-Jiao Wen
SGShan-Yan Gao
Shan-Yan Gao
Background: To examine associations between accelerometer-derived active weekend warrior (WW) pattern [most moderate to vigorous-intensity physical activity (MVPA) achieved over 1–2 days] vs. MVPA spread more evenly with risks of incident probable sarcopenia, sarcopenia and falls. Methods and findings: This prospective cohort study comprises three substudies (probable sarcopenia, confirmed sarcopenia and falls). Objective physical activity data were collected from Axivity AX3 wrist-worn triaxial accelerometers on their dominant wrist for 7 consecutive days. Three MVPA patterns were compared: active WW (≥150 min/week and ≥50% of total MVPA over 1–2 days), active regular (≥150 min/week but not meeting active WW), and inactive (<150 min/week). Over 7.8 years median follow-up, there were 1785 (8.4%) incident (probable) sarcopenia, 1855 (8.7%) incident sarcopenia and 4166 (4.9%) incident falls. Compared to inactive participants, the effect sizes for active WW pattern at the guideline-based threshold with ≥50% of total MVPA over 1–2 days were: probable sarcopenia {hazard ratio [HR], 0.79 [95% confidence interval (CI), 0.70–0.89], P = 1.5 × 10−4}, sarcopenia [HR, 0.74 (95% CI, 0.63–0.87), P = 6.6 × 10−4], falls [HR, 0.79 (95% CI, 0.72–0.85), P = 7.4 × 10−8] and recurrent falls [HR, 0.82 (95% CI, 0.75–0.90), P = 9.1 × 10−5]. The active WW pattern was associated with a 24%–32% reduction in the risk of (probable) sarcopenia, while active regular pattern was associated with a 12%–23% reduction in the risk. Regardless of the thresholds defining the active WW group, both activity patterns (active regular and active WW) showed a lower risk of falls. Conclusions: Weekly physical activity concentrated in 1–2 days had a similarly low risk of sarcopenia and falls as a regular active pattern. Even resistance training 1–2 days per week can serve as an effective public-health strategy for preventing sarcopenia and falls.

5 March 2026 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
FSFa Shen
Fa Shen
HLHao-Yu Liu
Hao-Yu Liu
YLYu-Yang Liu
Yu-Yang Liu
JYJia-Qi Yang
Jia-Qi Yang
LZLi-Wen Zhang
Li-Wen Zhang
SGShan-Yan Gao
Shan-Yan Gao